JANUARY 29, 2021 // -- The presence of SARS-CoV-2 variants in the fight against COVID-19 adds twists and turns, indicating the need for better genomic monitoring of the virus, said Katia Koell, associate professor of biology at Emory University.
Regenerative meta "stone man disease" new drug Phase 2 clinical success
Time of Update: 2021-03-03
, regenerative meta announced the results of a trial of clinical LULINA-1 phase 2 in the treatment of aggressive musculoskeletalization (Fibrodysplasia Ossificans Progressiva, FOP) in the new drug garetosmab. Preliminary analysis after 28
Proteomics studies have helped identify potential drugs against SARS-CoV-2
Time of Update: 2021-03-03
researchers at the University of California have been studying proteins used by SARS-CoV-2 virus to bind to lung proteins and have identified a variety of drugs that could be useful for treating COVID-19 patients.
Asasin Pharma won the 10th FDA Orphan Drug Certification, and Bcl-2 inhibitor APG-2575 added one
Time of Update: 2021-03-03
HK) announced today that the U.S. Food and Drug Administration (FDA) has awarded the company the qualification of the original innovative drug Bcl-2 inhibitor APG-2575 orphan drug for the treatment of fable lymphoma (FL).
: routine refrigeration, 2-pin immunity, global non-profit supply!
Time of Update: 2021-03-03
The European Commission (EC) has granted COVID-19 Vaccine AstraZeneca Conditional Listing Permit (CMA) for active immunization of people 18 years of age and older to prevent new coronavirus pneumonia (COVID-19) caused by the new coronavirus (SARS-CoV-2).
Lilly REYVOW treatment of migraine phase 2 clinical results were positive
Time of Update: 2021-03-02
patients treated with REYVOW 200mg were 4.1 times more likely to receive continuous pain relief at 48 hours (15.4% to 4.3% ;p<0.001) in the placebo group.
Tiantian Bio and Genexine announced that TJ107 has been approved for Clinical Phase 2 trials
Time of Update: 2021-03-02
medical need for patients with glioblastoma," said Dr. Sein Huajun, ceo of Tiantian Bio. This is one of the most invasive brain tumors, and the prognostication of patients has not improved significantly due to limited treatment options. Tiantian Bio
Elasmogen has been awarded a total of 2 million pounds to support the next generation of biologics
Time of Update: 2021-03-01
Elasmogen's proprietary humanized version of the drug, also known as SoloMER biologics, was originally based on a protein found in nature called VNAR.
2-D Electrophoresis Using Carrier Ampholytes in the First Dimension (IEF)
Time of Update: 2021-03-01
Two-dimensional electrophoresis (2-DE) is potentially the most powerful technique known for resolving complex protein mixtures.
Staining of Preparative 2-D Gels: Coomassie Blue and Imidazole-Zinc Negative Staining
Time of Update: 2021-02-28
Fig. 1. Preparative 2-D gels stained by the imidazole-zinc negative stain (left) and colloidal Coomassie blue G-250 stain (right).
Characterizing Proteins from 2-DE Gels by Internal Sequence Analysis of Peptide Fragments: Strategies for Microsample Handling
Time of Update: 2021-02-27
Considerable effort has also been expended to interface in situ digestion with micro-liquid chromotography (LC), peptide sequencers, and mass spectrometers.
Connbey's first three-quarter results exceeded last year's full-year stake in the company increased to 4.38 percent
Time of Update: 2021-02-27
and Biopharmaceus Co., Ltd. equity structure adjustment, accelerate the issuance and listing of shares in the overseas recognized qualified international securities market. At the same time, included in the company's plan of generic drug varieties
Plos Genet: Ordinary people are naturally resistant to SARS-CoV-2
Time of Update: 2021-02-27
FEBRUARY 12, 2021 /--- According to a study published February 11 in the open-access journal PLOS Pathogen, in the majority of severe cases of COVID-19, most people can produce meso-antibodies against SARS-CoV-2.
